Geode Capital Management
COYA icon

Geode Capital Management’s Coya Therapeutics COYA Stock Holding History

Geode Capital Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
228,243
-5,159
-2% -$23.9K ﹤0.01% 3285
2026
Q1 		$920K Buy
233,402
+35,414
+18% +$166K ﹤0.01% 3385
2025
Q4 		$1.15M Buy
197,988
+41,143
+26% +$250K ﹤0.01% 3330
2025
Q3 		$894K Sell
156,845
-242
-0.2% -$1.47K ﹤0.01% 3417
2025
Q2 		$903K Buy
157,087
+1,258
+0.8% +$7.29K ﹤0.01% 3357
2025
Q1 		$1.01M Buy
155,829
+5,253
+3% +$33.3K ﹤0.01% 3303
2024
Q4 		$863K Buy
150,576
+8,267
+6% +$56.3K ﹤0.01% 3422
2024
Q3 		$918K Buy
142,309
+4,485
+3% +$28.3K ﹤0.01% 3384
2024
Q2 		$835K Buy
137,824
+11,828
+9% +$95K ﹤0.01% 3379
2024
Q1 		$1.25M Buy
125,996
+33,531
+36% +$263K ﹤0.01% 3280
2023
Q4 		$685K Buy
92,465
+5,400
+6% +$30K ﹤0.01% 3495
2023
Q3 		$337K Buy
87,065
+28,492
+49% +$113K ﹤0.01% 3767
2023
Q2 		$238K Buy
+58,573
New +$272K ﹤0.01% 3965

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management's COYA Position: Q2 2026 in Review

Geode Capital Management reduced its Coya Therapeutics (COYA) stake by 2.2% in Q2 2026, selling an estimated $23.9K and leaving 228,243 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3285.

Geode Capital Management first reported a position in COYA in Q2 2023 and has held it in 13 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Geode Capital Management held 228,243 shares of Coya Therapeutics worth $1.34M as of Q2 2026.
  • Geode Capital Management sold 5,159 Coya Therapeutics shares in Q2 2026, an estimated $23.9K.
  • Coya Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3285 holding.
  • Geode Capital Management first reported a position in Coya Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.